نتایج جستجو برای: osteosarcoma cells

تعداد نتایج: 1390988  

2017
Amanda Dos Santos Cavalcanti Walter Meohas Gabriele de Oliveira Ribeiro Ana Cristina de Sá Lopes Sharareh Gholamin Mostafa Razavi Taís Hanae Kasai Brunswick Amir Avan João Antonio Matheus Guimarães Maria Eugenia Leite Duarte Suzana Assad Kahn

Osteosarcoma is the most common primary bone tumor in children and young adults. The median survival of osteosarcoma patients has not significantly improved since 1990, despite administration of different classes of chemotherapy agents, such as methotrexate, cisplatin and doxorubicin. Cancer stem cells (CSCs) are responsible for the resistance of osteosarcoma to chemotherapy and OCT4, SOX2 and ...

Journal: :Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2014
Jian Chen Haijian Fu Zhuoying Wang Fei Yin Jianxin Li Yingqi Hua Zhengdong Cai

BACKGROUND Osteosarcoma is the most common primary malignant bone tumor in children and adolescents and is characterized by frequent metastasis and resistance to chemotherapy. Because osteosarcoma cells are not highly susceptible to current chemotherapy drugs, new alternative strategies for the treatment of osteosarcoma are needed. This study was undertaken to investigate the inhibitory effects...

2017
Xiucheng Li Zhifan Yang Weiqi Han Xuanyuan Lu Songtao Jin Wanlei Yang Jianlei Li Wei He Yu Qian

Osteosarcoma is the most common malignant bone tumor. Most patients diagnosed with osteosarcoma are less than 20 years of age. Osteosarcoma cells proliferate rapidly and invade other tissues. At present, neoadjuvant chemotherapy is the primary pharmacodynamic strategy to prevent the progression of osteosarcoma. However, adverse effects of this strategy limit its long‑term application. Previous ...

Journal: :Clinical and translational discovery 2023

Background Osteosarcoma (OS) is a prevalent bone cancer characterized by its aggressive nature, which often metastasizes to the lungs and contributes poor prognosis. Treatment progress has been hindered drug resistance, distant metastases, significant patient heterogeneity. However, recent advancements in technologies such as sequencing multi-omics have enabled more in-depth investigations at m...

Journal: :Molecular cancer research : MCR 2012
Takatsune Shimizu Tomoki Ishikawa Sayaka Iwai Arisa Ueki Eiji Sugihara Nobuyuki Onishi Shinji Kuninaka Takeshi Miyamoto Yoshiaki Toyama Hiroshi Ijiri Hajime Mori Yumi Matsuzaki Tomonori Yaguchi Hiroshi Nishio Yutaka Kawakami Yasuo Ikeda Hideyuki Saya

Osteosarcoma is the most frequent, nonhematopoietic, primary malignant tumor of bone. Histopathologically, osteosarcoma is characterized by complex mixtures of different cell types with bone formation. The role of environmental factors in the formation of such a complicated tissue structure as osteosarcoma remains to be elucidated. Here, a newly established murine osteosarcoma model was used to...

Background and Aim: In the present studysynthesis of silver nanoparticles and the assessment of its toxicity against the proliferation of osteosarcoma cells were done. Materials and Methods: To confirm the production of silver nanoparticles, UV-Visible spectroscopy, X-ray diffraction, and TEM analyses were performed. MTT assay was used to evaluate the toxicity of nanoparticles against cancer c...

Journal: :Molecular cancer research : MCR 2014
Tetsuro Ohba Justin M M Cates Heather A Cole David A Slosky Hirotaka Haro Takashi Ando Herbert S Schwartz Jonathan G Schoenecker

UNLABELLED Osteosarcoma is the most common primary bone malignancy and accounts for more than half of primary skeletal malignancies in children and young adults. Although vascular endothelial growth factor (VEGF) expression in osteosarcoma has been associated with poor outcome, its role in the pathogenesis of osteosarcoma remains controversial. Here, VEGF and VEGFR1 expression in both human and...

2015
YULONG LIU YE LI JINGCHEN LIU YUNTAO WU QINGSAN ZHU

Increasing evidence has confirmed that dysregulation of microRNAs (miRNAs) can contribute to the progression and metastasis of human tumors. Previous studies have shown that dysregulation of microRNAs (miRNAs) can contribute to the progression and metastasis of human tumors. However, the precise mechanisms of miR‑132 in osteosarcoma have not been well clarified. Real-time PCR was performed to d...

2017
Gang Yin Jin Fan Wei Zhou Qingfeng Ding Jun Zhang Xuan Wu Pengyu Tang Hao Zhou Bowen Wan Guoyong Yin

mTOR is a valuable oncotarget for osteosarcoma. The anti-osteosarcoma activity by a novel mTOR kinase inhibitor, CZ415, was evaluated. We demonstrated that CZ415 potently inhibited survival and proliferation of known osteosarcoma cell lines (U2OS, MG-63 and SaOs2), and primary human osteosarcoma cells. Further, CZ415 provoked apoptosis and disrupted cell cycle progression in osteosarcoma cells....

2014
Yun-Shan Guo Rui Zhao Jie Ma Wei Cui Zhen Sun Bo Gao Shu He Yue-Hu Han Jing Fan Liu Yang Juan Tang Zhuo-Jing Luo

Osteosarcoma, the most common primary bone tumor in children and young adolescents, is characterized by local invasion and distant metastasis. But the detailed mechanisms of osteosarcoma metastasis are not well known. In the present study, we found that βig-h3 promotes metastatic potential of human osteosarcoma cells in vitro and in vivo. Furthermore, βig-h3 co-localized with integrin α2β1 in o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید